Zhejiang Xianju Pharmaceutical Co Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Xianju Pharmaceutical Co Limited with three other
companies in this sector in China:
Zhejiang Hisoar Pharmaceutical Co. Ltd
sales of 2.43 billion Chinese Renmimbi [US$353.24 million]
of which 52%
was Pharmatheutical Industry),
Chengdu Kanghong Pharmaceuticals Group Co Ltd
(2.54 billion Chinese Renmimbi [US$368.64 million]
of which 100%
was Pharmaceutical Manufacturing), and
Heilongjiang ZBD Pharmaceutical Co Ltd
(2.39 billion Chinese Renmimbi [US$347.10 million]
of which 79%
was Pharmaceutical Industry).
Zhejiang Xianju Pharmaceutical Co Limited reported sales of 2.50 billion Chinese Renmimbi (US$363.37 million)
December of 2016.
a very small
increase of 1.0%
versus 2015, when the company's sales were 2.48 billion Chinese Renmimbi.
Sales at Zhejiang Xianju Pharmaceutical Co Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 48%).
Sales of Medicine saw an increase
1.0% in 2016, from
2.47 billion Chinese Renmimbi to 2.49 billion Chinese Renmimbi.
Not all segments of Zhejiang Xianju Pharmaceutical Co Limited experienced an increase in sales in 2016:
sales of Other fell 4.3% to 11.25 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).